This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • relative risk of stroke in rheumatic heart disease with atrial fibrillation was 17.6 times higher than in normal controls
  • atrial fibrillation associated with non-rheumatic heart disease was associated with a 5.6 times increase in risk of stroke relative to normal controls
  • the risk of stroke for lone atrial fibrillation was 4 times normal controls
    • comorbidities significantly modulate progression and complications of atrial fibrillation. Age or development of hypertension increases thromboembolic risk (2)
  • risk of embolization in paroxysmal atrial fibrillation is uncertain
  • female sex in patients with AF without rheumatic heart disease is associated with a higher risk of stroke
  • underlying heart disease increases the risk of stroke in non-rheumatic atrial fibrillation
  • up to 20% of patients with atrial fibrillation and a stroke will have a second stroke within one year
  • a third of patients with paroxysmal atrial fibrillation develop chronic atrial fibrillation over two to three years
  • in a follow-up of the Framingham study, atrial fibrillation was independently associated with a 50-90% increase in the risk of death
    • Ponamgi et al have stated that atrial fibrillation is associated with a nearly twofold excess risk of all cause mortality (3)

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.